| MCYCX | VEMRX | MCYCX / VEMRX | |
| Total Expense Ratio | 2.23 | 0.07 | 3,186% |
| Annual Report Gross Expense Ratio | 2.46 | 0.07 | 3,514% |
| Fund Existence | 8 years | 15 years | - |
| Gain YTD | 33.167 | 24.460 | 136% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 141B | 0% |
| Annual Yield % from dividends | 0.00 | 2.80 | - |
| Returns for 1 year | 32.77 | 22.70 | 144% |
| Returns for 3 years | 54.75 | 51.08 | 107% |
| Returns for 5 years | 17.08 | 28.16 | 61% |
| Returns for 10 years | N/A | 88.60 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNCX | 67.55 | -0.35 | -0.52% |
| Janus Henderson Global Life Sciences C | |||
| QDVSX | 20.78 | -0.24 | -1.14% |
| FI Instl ESG Stck Fd for Ret Plns | |||
| LICFX | 18.37 | -0.23 | -1.24% |
| Lord Abbett International Equity F | |||
| IVVYX | 25.14 | -0.37 | -1.45% |
| Macquarie International Core Eq Y | |||
| NELAX | 64.33 | -0.97 | -1.49% |
| Nuveen Equity Long/Short A | |||